Thursday 22 October 2009

Mike Lucas on Low Dose Naltrexone

Michael Moore's colleague Mike Lucas weighs on the Low Dose Naltrexone issue -

Why won’t the drug companies shell out cash for a promising drug that requires FDA approval?

No comments:

Post a Comment